Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension

Table 5

Live functions at one week and last follow-up.

	TIPS ()	OCT-LAR ()
One week
AST (U/L)	101.8 ± 49.2	90.1 ± 40.6	0.53
ALT (U/L)	104.8 ± 48.1	99.6 ± 50.6	0.80
TB (μmol/L)	53.4 ± 11.2	48.6 ± 11.6	0.34
PT (s)	17.5 ± 1.3	17.8 ± 2.1	0.63
Last follow-up
AST (U/L)	85.8 ± 44.6	81.8 ± 41.6	0.82
ALT (U/L)	91.8 ± 49.5	80.3 ± 38.2	0.53
TB (μmol/L)	45.4 ± 11.7	42.1 ± 9.7	0.47
PT (s)	16.1 ± 1.0	17.0 ± 1.7	0.13